| Effect of Ellagic Ácid on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | Effect of Ellagic Acid Administration on the Components of Metabolic Syndrome, Insulin Sensitivity and Insulin Secretion | NCT04011618 |
| The Effects of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid on Healthy Male Subjects | Exploratory Study to Determine the Bioavailability and Metabolism of Ellagic Acid From Pomegranate Juice vs. Pure Ellagic Acid | NCT03713164 |
| A New Supplement for the Immune Response to HPV Infection | Ellagic Acid and Annona Muricata May Modulate the Immune Response to High Risk HPV Infection. A Randomized, Controlled Trial. | NCT02263378 |
| Evaluation of the effects of Ellagic acid on patients with myocardial infarction | Evaluation of the effects of Ellagic acid on the hs-CRP level in patients with myocardial infarction | IRCT20220516054874N8 |
| Ellagic acid in multiple sclerosis | Effect of Ellagic acid supplementation on disease severity, expression of involved genes in pathogenesis, and levels of immunity and inflammatory biomarkers in patients with Multiple Sclerosis | IRCT20120415009472N22 |
| Ellagic acid supplementation in women with the poly cystic ovarian syndrome | Assessment of the ellagic acid supplementation effect on insulin resistance, oxidative stress and sex hormones levels in women with the Polycystic ovary syndrome. | IRCT20141025019669N12 |
| Evaluation of the effects of Ellagic acid on inflammation and insulin resistance in patients with Type 2 diabetes mellitus and acute coronary syndrome | Evaluation of the effects of Ellagic acid on inflammation and insulin resistance in patients with Type 2 diabetes mellitus and acute coronary syndrome | IRCT20220516054874N14 |
| A study to evaluate the effectiveness of a newly formulated solution containing ellagic acid and sodium hyaluronate compared to standard treatment for enhancing eyelash growth. | Formulation of topical solution / ointment incorporating ellagic acid and sodium hyaluronate and evaluating their relative effectiveness in promoting eyelash growth comparing with standard treatment. - Nil | CTRI/2024/11/077449 |
| A clinical trial to study the effects of two gum ointments ellagic acid and tannic acid gum ointment in treating gum diseases | Comparing the efficacy of Ellagic Acid and Tannic acid Gum paint in gingivitis patients aged 17-25 years - A Randomized Control Trial - NIL | CTRI/2024/01/061530 |
| Ellagic acid supplementation in patient with irritabe bowel syndrome | The effects of oral supplementation ellagic acid on anti-oxidant status, inflammatory markers, and quality of life in a patient with irritabe bowel syndrome: randomized double-blind clinical trial | IRCT20141025019669N11 |
| Ellagic acid supplementation in patients with non-alcoholic fatty liver disease | Assessment of the Ellagic acid supplementation effect on lipid profile, liver enzymes, oxidative stress status and inflammatory factors in patients with non-alcoholic fatty liver disease: double-blind randomized clinical trial | IRCT20141025019669N21 |
| Evaluation of the effectiveness of ellagic acid on patients with non-alcoholic fatty liver disease | Evaluation of the effectiveness of ellagic acid on liver steatosis in patients with non-alcoholic fatty liver disease | IRCT20180103038199N16 |
| Ellagic acid supplementation effect in patients with type 2 diabetes | Assessment the ellagic acid supplementation effect on glycemic status, insulin resistance, inflammatory factors, antioxidant status and expression of miR146-a in patients with type 2 diabetes: double blind randomized clinical trial | IRCT20141025019669N13 |
| Ellagic acid supplementation effect in patients with Major Depressive | Evaluating the Effect of Ellagic Acid Supplementation on Antioxidant Status in Patients with Major Depressive Disorder: A randomized, double-blind clinical trial | IRCT20141025019669N15 |
| The effect of exercise and supplementation of ellagic acid on obesity | Effect of 8 weeks of High Intensity Interval Training with supplemental Ellagic acid on serum levels of some oxidative and antioxidant factors in obese women. | IRCT20191020045170N1 |
| Ellagic acid in multiple sclerosis | The effect of Ellagic acid on depression, inflammatory index (IFN-?), oxidative (Nrf2) and nitrosative (NO) stress index, Brain Derived Neurotrophic Factor (BDNF), cortisol, serotonin and gene expression of indoleamine dioxygenase enzyme in patients with multiple sclerosis | IRCT20091114002709N54 |
| Ellagic acid and type 2 diabetes | The effect of ellagic acid supplementation on glycemic status, lipid profile, oxidative stress indices and anthropometric parameters in the military with type 2 diabetes | IRCT20210219050412N1 |
| The effect of Ellagic acid supplementation in patients with type 2 diabetes | The effect of ellagic acid supplementation on glycemic indices, lipid profile, anthropometric, inflammatory and oxidative indices, dietary intake and serum levels of pentosidine, adiponectin and resistin in patients with types 2: a double-blind, randomized controlled clinical trial | IRCT20121028011288N18 |
